Advertisement
Loading...

BioXcel Therapeutics, Inc.

BTAI•NASDAQ
Healthcare
Biotechnology
$1.13
$-0.01(-0.88%)
U.S. Market opens in 1h 36m
Advertisement

BioXcel Therapeutics, Inc. (BTAI) Stock Overview

Explore BioXcel Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap34.9M
P/E Ratio-0.18
EPS (TTM)$-4.77
ROE0.76%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.07
3 Months$0.18
1 Year Target$0.00

BTAI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioXcel Therapeutics, Inc. (BTAI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.11, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.18 and a market capitalization of 34.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.88%
5-Day Change
3.67%
1-Month Change
6.60%
3-Month Change
-31.93%
6-Month Change
-40.84%
Year-to-Date (YTD) Change
-29.38%
1-Year Change
-18.71%
3-Year Change
-99.63%
5-Year Change
-99.77%
All-Time (Max) Change
-99.36%

Contact Information

https://www.bioxceltherapeutics.com
475 238 6837
555 Long Wharf Drive, New Haven, CT, 06511

Company Facts

37 Employees
IPO DateMar 8, 2018
CountryUS
Actively Trading

Frequently Asked Questions